LNWTC
TEVA icon

Laird Norton Wetherby Trust Company’s Teva Pharmaceuticals TEVA Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
17,179
+3,118
+22% +$104K 0.01% 667
2026
Q1 		$424K Sell
14,061
-3,674
-21% -$118K 0.01% 739
2025
Q4 		$554K Buy
+17,735
New +$437K 0.01% 681

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Laird Norton Wetherby Trust Company's TEVA Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Teva Pharmaceuticals (TEVA) stake by 22% in Q2 2026, buying an estimated $104K and bringing the position to 17,179 shares worth $582K. The position accounts for 0.01% of the portfolio, ranked #667.

Laird Norton Wetherby Trust Company first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 17,179 shares of Teva Pharmaceuticals worth $582K as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 3,118 Teva Pharmaceuticals shares in Q2 2026, an estimated $104K.
  • Teva Pharmaceuticals made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #667 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.